The Food and Drug Administration (FDA) is apparently eyeing new regulations for certain CBD products, with an announcement from the federal agency expected in the coming months.
The Wall Street Journal, citing agency officials, reported this week that the FDA is “studying whether legal cannabis is safe in food or supplements and plans to make recommendations for how to regulate the growing number of cannabis-derived products in the coming months.”
“Given what we know about the safety of CBD so far, it raises concerns for FDA about whether these existing regulatory pathways for food and dietary supplements are appropriate for this substance,” Janet Woodcock, the Food and Drug Administration’s principal deputy commissioner, told the Wall Street Journal.
According to the newspaper, Woodcock has “led the agency’s efforts looking at cannabis regulation.”
Reuters reports that, “after weighing the evidence on the compound’s safety, the FDA will decide within months how